Results

Total Results: 1,223 records

Showing results for "indication".
Users also searched for: medication reconciliation

1. 012695_02-2004.pmd (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/QETZFZLBsJbtPmVNVCgA7Z
   May 01, 1993 - Scoring: Item responses on the CAGE are scored 0 or 1, with a higher score an indication of alcohol … Scoring: Item responses on the CAGE are scored 0 or 1, with a higher score an indication of alcohol

2. Draft Research Plan: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/aspirin-use-to-prevent-preeclampsia-and-related-morbidity-and-mortality-preventive-medication1
   June 20, 2019 - Chorioamnionitis Child behavioral or developmental problems Length of hospital stay (without indication

3. Draft Research Plan: Hypertensive Disorders of Pregnancy: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/hypertensive-disorders-pregnancy-screening
   May 20, 2021 - Reduced quality of life Nonclinical health outcomes, such as length of hospital stay (without indication

4. Final Research Plan: Aspirin Use to Prevent Preeclampsia and Related Morbidity and Mortality: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
   September 26, 2019 - Chorioamnionitis Child behavioral or developmental problems Length of hospital stay (without indication

5. Final Research Plan: Hypertensive Disorders of Pregnancy: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/hypertensive-disorders-pregnancy-screening
   September 02, 2021 - Reduced quality of life Nonclinical health outcomes, such as length of hospital stay (without indication

6. USPSTF Clinician Summary of USPSTF Recommendation: Preexposure Prophylaxis to Prevent Acquisition of HIV (pdf file)
   www.uspreventiveservicestaskforce.org/home/getfilebytoken/MpvsVJg4_V_3jxbkSyK_Ua
   August 01, 2023 - • No PrEP medications have FDA approval for the indication of reducing the risk of acquiring HIV via

7. Final Research Plan: Preeclampsia: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan109/preeclampsia-screening
   August 14, 2014 - patient stress and anxiety Nonclinical health outcomes, such as length of hospital stay (without indication

8. Archived: Final Research Plan: Preeclampsia: Screening | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan109/preeclampsia-screening-april-2017
   August 14, 2014 - patient stress and anxiety Nonclinical health outcomes, such as length of hospital stay (without indication

9. Final Research Plan: Vitamin, Mineral, and Multivitamin Supplementation to Prevent Cardiovascular Disease and Cancer: Preventive Medication | United States Preventive Services Taskforce
   www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/vitamin-supplementation-to-prevent-cvd-and-cancer-preventive-medication
   September 05, 2019 - enzymes, proprietary products, fiber, garlic, or turmeric), or vitamin-derived agents with dermatologic indication

10. Final Research Plan: Gynecological Conditions: Periodic Screening With the Pelvic Examination | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan137/gynecological-conditions-screening-with-the-pelvic-examination
    March 05, 2015 - current review because pelvic examinations performed in these populations are often for a different indication

11. Procedure Manual Appendix XII. Summary of Evidence Table for Evidence Reviews | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/procedure-manual/procedure-manual-appendix-xii-summary-evidence-table-evidence-reviews
    July 01, 2017 - and predictive intervals, if warranted) or qualitative findings for each important outcome, with some indication

12. Procedure Manual Appendix XII. Summary of Evidence Table for Evidence Reviews | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-xii-summary-evidence-table-evidence-reviews
    July 01, 2017 - and predictive intervals, if warranted) or qualitative findings for each important outcome, with some indication

13. Archived: Published Comment - Will Recommendations against Spirometry Make Chronic Obstructive Pulmonary Disease Harder to Treat?: Chronic Obstructive Pulmonary Disease (COPD): Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/published-comment---will-recommendations-against-spirometry-make-chronic-obstructive-pulmonary-disease-harder-to-treat/chronic-obstructive-pulmonary-disease-copd-screening
    November 15, 2008 - If spirometry use in a group with a clear-cut indication is so low, one can imagine that use in patients

14. Archived: Published Comment - Will Recommendations against Spirometry Make Chronic Obstructive Pulmonary Disease Harder to Treat?: Chronic Obstructive Pulmonary Disease (COPD): Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/published-comment---will-recommendations-against-spirometry-make-chronic-obstructive-pulmonary-disease-harder-to-treat/chronic-obstructive-pulmonary-disease-copd-screening-2008
    November 15, 2008 - If spirometry use in a group with a clear-cut indication is so low, one can imagine that use in patients

15. Final Research Plan: Vitamin D, Calcium, or Combined Supplementation for the Primary Prevention of Fractures in Community-Dwelling Adults: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/vitamin-d-calcium-or-combined-supplementation-for-the-primary-prevention-of-fractures-in-adults-preventive-medication
    June 23, 2016 - In response to comments, the USPSTF revised the key question regarding harms to remove indication of

16. Evidence Summary: Hypertension in Adults: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hypertension-in-adults-screening
    April 27, 2021 - Sensitivity and specificity were 0.94 and 0.76, respectively, for the subgroup (n = 126) for whom the ABPM indication … Indication-specific 6-h systolic blood pressure thresholds can approximate 24-h determination of blood … 0.92) and specificities (0.25-0.97) Truncated vs 24-h ABPM: 1 study reporting separate analyses by indication … ; sensitivity and specificity were 0.94 and 0.76, respectively, for ABPM indication of borderline HTN … (n = 126) and 0.89 and 0.70 for the ABPM indication of suspected white coat HTN (n = 137) Repeat

17. Archived: Final Research Plan: Aspirin to Prevent Cancer: Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan-aspirin-to-prevent-cancer/aspirin-to-prevent-cardiovascular-disease-and-cancer-april-2016
    October 07, 2013 - Category Included Excluded Aim/Condition Any indication; cancer incidence and deaths reported

18. Archived: Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: Preventive Medication | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/recommendation/ocular-prophylaxis-for-gonococcal-ophthalmia-neonatorum-preventive-medication-2011
    July 15, 2011 - Food and Drug Administration for this indication is 0.5% erythromycin ophthalmic ointment.

19. Ocular Prophylaxis for Gonococcal Ophthalmia Neonatorum: USPSTF Reaffirmation Recommendation Statement (pdf file)
    www.uspreventiveservicestaskforce.org/home/getfilebytoken/wAvC6HSumLETsanNkHHXu9
    April 01, 2011 - Food and Drug Administration for this indication is 0.5% erythromycin ophthalmic ointment.

20. Final Research Plan: Latent Tuberculosis Infection: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan105/latent-tuberculosis-infection-screening
    September 25, 2014 - The USPSTF also removed any indication of a preferential order of sequential testing or of TST as a reference